Tenon Medical, Inc. (TNON): Nasdaq/NYSE listing notice — Tenon Medical receives Nasdaq deficiency notice for bid price below $1.00 per share

Tenon Medical, Inc.

Nasdaq letter dated July 20, 2023; common stock failed to maintain $1.00 minimum bid for 30 consecutive days (June 6-July 19, 2023).
Initial 180-day compliance period runs to January 16, 2024; must close at $1.00+ for 10 consecutive trading days to regain compliance.
If not cured by Jan 16, company may qualify for an additional 180-day period by meeting other listing standards and potentially executing a reverse stock split.
Stock continues trading on The Nasdaq Capital Market under symbol TNON while company evaluates options to regain compliance.
No assurance of regaining compliance; failure could lead to delisting and a potential appeal to a Nasdaq hearings panel.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Tenon Medical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

ule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial

View on SEC.gov

Browse all listing & compliance notices →

Tenon Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-058916

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.